magnifying glass
logo for Scancell Holdings

Scancell Holdings

Business Services · United Kingdom · 25 Employees

Get Full Access

Who is Scancell Holdings

Scancell is developing novel therapeutic vaccines for the treatment of cancer and infectious diseases based on its groundbreaking ImmunoBody® technology platform. Scancell's first cancer vaccine SCIB1 is being developed for the treatment of melanoma and has recently entered clinical trials. Treating cancer by vaccination allows small non-toxic doses of a vaccine to be administered to a patient, stimulating an immune response. Effective cancer vaccines need to target dendritic cells to stimulate both parts of the cellular immune system; the helper cell system where inflammation is stimulated at the tumour site; and the cytotoxic T-lymphocyte or CTL response where immune system cells are primed to recognise and kill specific cells. A limitation of many cancer vaccines currently in development is that they cannot specifically target dendritic cells in vivo. Several groups have demonstrated successful vaccination by growing dendritic cells ex vivo, pulsing them with tumour antigens and re-infusing them. However, this procedure is patient specific, time consuming and expensive. Scancell has developed its breakthrough patent protected ImmunoBody® technology to overcome these limitations. An ImmunoBody® is a human antibody or fusion protein engineered to express helper cell and CTL epitopes from tumour antigens over-expressed by cancer cells. Antibodies are ideal vectors for carrying T cell epitopes from tumour antigens as they have long half-lives and can effectively target dendritic cells via their Fc receptors, allowing efficient stimulation of both helper and CTL responses. The Immunobody® technology can be adapted to provide the basis for treating any tumour type and may also be of potential utility in the development of vaccines against hepatitis, HIV and other chronic infectious diseases.Read More

Headquarters

Headquarters:

John Eccles House Robert Robinson Ave, Oxford, Oxfordshire, OX4 4GP, United Kingdom
Phone Number

Phone Number:

+44 1865 338069
Revenue

Revenue:

<$5 Million
Stock Symbol

Stock Symbol:

SCLP
Scancell Holdings's Social Media
SIC Code 87,873
NAICS Code 541,541714
Ticker AIM: SCLP
Popular Searches:

SCANCELL HOLDINGS PLC

Scancell

Scancell Limited

Scancell Ltd

Scancell Holdings

Top Competitors of Scancell Holdings

Employess
<25
revenue
<$5 Million

2

Employess
76
revenue
$14 Million

3

Employess
<25
revenue
<$5 Million

4

Employess
<25
revenue
<$5 Million

5

Employess
62
revenue
<$5 Million

6

Employess
40
revenue
<$5 Million

7

Employess
<25
revenue
<$5 Million

8

Illustration of an envelope

Scancell Holdings's Tech Stack

Twitter Cards

By

Twitter

Google Workspace (formerly G Suite)

By

Google

Cloudflare DNS

By

Cloudflare

Cloudflare Security

By

Cloudflare
See more technologies

Scancell Holdings News & Media

PharmaJet selected to deliver Scancell COVID-19 DNA Vaccines

GOLDEN, Colo.--(BUSINESS WIRE)--PharmaJet and Scancell partner to deliver COVID-19 DNA Vaccines exclusively using the PharmaJet Needle-free delivery systems

Proactive news headlines: NetScientific, Arecor Therapeutics, Silence Therapeutics, Scancell Holdings...

NetScientific PLC's (LON:NSCI) ProAxsis subsidiary has struck a licensing deal with AstraZeneca PLC (LON:AZN) over the validation and global commercialisation of an assay associated with coronavirus vaccines. Seeing Machines Limited (LON:SEE) said there is “additional momentum” in the US market for mandatory driver monitoring system technology following the introduction of the 21st Century Smart Cars Act to the US Congress. Mkango Resources Ltd (LON:MKA, TSX-V:MKA) and Grupa Azoty PULAWY have ag
Subscribe to "Scancell Holdings" News

Frequently Asked Questions regarding Scancell Holdings

Where are Scancell Holdings’s headquarters?

Scancell Holdings’s headquarters are in John Eccles House Robert Robinson Ave, Oxford, Oxfordshire, OX4 4GP, United Kingdom

What is Scancell Holdings’s phone number?

Scancell Holdings’s phone number is +44 1865 338069

What is Scancell Holdings’s stock symbol?

Scancell Holdings’s stock symbol is SCLP

What is Scancell Holdings’s official website?

Scancell Holdings’s official website is www.scancell.co.uk

What is Scancell Holdings’s Revenue?

Scancell Holdings’s revenue is <$5 Million

What is Scancell Holdings’s SIC code?

Scancell Holdings’s SIC: 87,873

What is Scancell Holdings’s NAICS code?

Scancell Holdings’s NAICS: 541,541714

How many employees are working in Scancell Holdings?

Scancell Holdings has 25 employees

What is Scancell Holdings’s industry?

Scancell Holdings is in the industry of: Business Services, Research & Development

Who are Scancell Holdings’s main competitors?

Scancell Holdings's main competitors are: Galenica Pharmaceuticals, Immunicum, Iomai, Precision Biologics

What is Scancell Holdings's tech stack?

The technologies that are used by Scancell Holdings are: Twitter Cards, Google Workspace (formerly G Suite), Cloudflare DNS, Cloudflare Security

See more information about Scancell Holdings
4.4/5 on G2 Crowd